Challenges and Thoughts Brought by the Development of Transplantation Technology to Clinical Blood Transfusion

doi:10.3969/j.issn.1671-2587.2021.05.001

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2021, Vol. 23 ›› Issue (5): 545-550.DOI: 10.3969/j.issn.1671-2587.2021.05.001

Challenges and Thoughts Brought by the Development of Transplantation Technology to Clinical Blood Transfusion

YIN Wen

Department of Blood Transfusion, Clinical Laboratory, Xijing Hospital, the Fouth Military Medical University, Xi'an 710032

Received:2021-07-23 Online:2021-10-20 Published:2021-10-20

Abstract

Abstract: Clinical blood transfusion and blood transfusion-related immunity are critical to the survival of the transplant. With the improvement of transplantation technology, liver transplantation, kidney transplantation, small intestine transplantation,lung transplantation uterus transplantation, hematopoietic stem cell transplantation have been realized, and xenogeneic organ transplantation is also actively exploring. Researchers have gradually gained a new understanding of transplantation-related blood transfusion. This paper expatiated on blood immunology related to organ transplantation and hematopoietic stem cell transplantation, perioperative blood transfusion during transplantation and xenotransplantation in the future, in order to provide new ideas for blood transfusion in transplantation technology.

Key words: Transplantation techniques, Blood group and clinical transfusion, Blood transfusion management, Xenotransplantation, Transplantation immunology

CLC Number:

R457.1

YIN Wen. Challenges and Thoughts Brought by the Development of Transplantation Technology to Clinical Blood Transfusion[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(5): 545-550.

References

[1] 夏爱军,张献清,胡兴斌,等.小肠移植患者ABO血型不合抗体效价监测(附1例报告)[J].中国输血杂志,2014,27(3):294-295.
[2] 汪昶,陈立中,邱江,等.ABO血型不合活体肾移植11例分析[J].器官移植,2019,10(2):182-186.
[3] 吴国生. 临床活体小肠移植国内外研究进展[J].中华结直肠疾病电子杂志,2013,2(5):221-223.
[4] KIMURA F,SATO K,KOBAYASHI S,et al.Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program[J].Haematologica,2008,93(11): 1686-1693.
[5] TEKGÜNDÜZ S A,ÖZBEK N.ABO blood group mismatched hematopoietic stem cell transplantation[J].Transfus Apher Sci,2016,54(1):24-29.
[6] RAMSEY G .Transfusion therapy in solid organ transplantation.In: Simon TL, Dzik WH, Sngder EL( ed) .Rossis Principles of Transfusion Medicine[M].3rd ed, Philadelphia :Lippincott Williams & Wilkins, 2002 .
[7] SIS B.Intragraft donor-specific antibody detection: a new test to dichotomize HLA alloantibodies into high and low injurious activity[J].Am J Transplant,2013,13(11):2787-2789.
[8] SENGUPTA P,BISWAS S,CHOWDHURY S,et al.Passenger lymphocyte syndrome in a renal transplant recipient[J].J Assoc Physicians India,2015,63(12):86-88.
[9] NISHIDE S,UCHIDA J,KABEI K,et al.Passenger lymphocyte syndrome in the ABO-incompatible kidney transplant recipient receiving rituximab[J].Exp Clin Transplant,2019,17(4):558-560.
[10] ROMERO S,SOLVES P,LANCHARRO A,et al.Passenger lymphocyte syndrome in liver transplant recipients: a description of 12 cases[J].Blood Transfus,2015,13(3):423-428.
[11] 明英姿,庄权,成柯,等.肝移植术后过客淋巴细胞综合征的发病机制和研究进展[J].器官移植,2017,8(4):316-319.
[12] 王文婷,张保萍,刘丽娜,等.过客淋巴细胞引起ABO非同型肝移植患者术后发生溶血反应1例[J].中国输血杂志,2016,29(2):207-209.
[13] CYWINSKI J B,ALSTER J M,MILLER C,et al.Prediction of intraoperative transfusion requirements during orthotopic liver transplantation and the influence on postoperative patient survival[J].Anesth Analg,2014,118(2):428-437.
[14] 王淑英,牛国涛,刘振红,等.135例肝移植患者围术期输血情况分析[J].临床输血与检验,2015,17(2): 135-138.
[15] CLEVENGER B,MALLETT S V.Transfusion and coagulation management in liver transplantation[J].World J Gastroenterol,2014,20(20):6146-6158.
[16] OPELZ G,WUJCIAK T.Cadaveric kidneys should be allocated according to the HLA match[J].Transplant Proc,1995,27(1):93-99.
[17] OPELZ G.Repeated HLA mismatches increase the failure rate of second kidney transplants.Collaborative Transplant Study[J].Transplant Proc,1995,27(1): 658-659.
[18] 郎嵘,王桂君,梁晓林,等.尿毒症患者输血对群体反应性抗体产生的影响[J].北京医学,2013,35(4):303-304.
[19] 王洪伟,郁雷,王锡山.小肠移植的研究进展及围手术期的注意要点[J].中华结直肠疾病电子杂志,2014,3(3): 192-194.
[20] 夏爱军,胡兴斌,安群星,等.小肠移植患者围术期成分输血治疗[J].中国输血杂志,2014,27(11):1163-1164.
[21] 欧阳振波,尹倩,全松,等.子宫移植的伦理学探讨[J].现代妇产科进展,2017,26(7):548-549.
[22] 欧阳振波,魏世远,盘翠丽,等.人子宫移植后临床妊娠并成功分娩活产儿案例分析[J].中华妇幼临床医学杂志(电子版),2020,16(1):93-99.
[23] 许金华,李晓丰.ABO血型不合异基因造血干细胞移植后血型转换期的输血策略[J].中国组织工程研究,2015,19(6):913-917.
[24] 杨世明,张勇萍,潘晓莉,等.异基因外周血造血干细胞移植后ABO血型抗原抗体效价的变化[J].细胞与分子免疫学杂志,2010,26(9):933-934.
[25] 曹晓明,田华,要军.ABO血型不合造血干细胞移植后血型转变的临床分析[J].北京医学,2008,30(4):242-243.
[26] LEE J H,LEE J H,CHOI S J,et al.Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation[J].Br J Haematol,2003,120(4):702-710.
[27] STALEY E M,SCHWARTZ J,PHAM H P.An update on ABO incompatible hematopoietic progenitor cell transplantation[J].Transfus Apher Sci,2016,54(3): 337-344.
[28] STUSSI G,HALTER J,BUCHELI E,et al.Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins[J].Haematologica,2009,94(2): 239-248.
[29] OZKURT Z N,YEGIN Z A,YENICESU I,et al.Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation[J].Transplant Proc,2009,41(9):3851-3858.
[30] TRELEAVEN J,GENNERY A,MARSH J,et al.Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force[J].Br J Haematol,2011,152(1):35-51.
[31] 张玄,王琳,张洪涛,等.多基因编辑猪-猴心脏、肝脏、肾脏移植临床前研究初步报道[J].器官移植,2021,12(1):51-56.
[32] YEH H,MACHAIDZE Z,WAMALA I,et al.Increased transfusion-free survival following auxiliary pig liver xenotransplantation[J].Xenotransplantation,2014,21(5):454-464.
[33] ZHANG X,LI X,YANG Z,et al.A review of pig liver xenotransplantation: Current problems and recent progress[J].Xenotransplantation,2019,26(3):e12497.

Challenges and Thoughts Brought by the Development of Transplantation Technology to Clinical Blood Transfusion

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 3

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	LIN Miao-xiong,GU Xiang-ming,PENG Ming,et al.. Analysis on the Status of Clinical Blood Transfusion in A Grade A Class 3 Hospital in Gongdong Province from 2010 to 2015 [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(4): 387-390.
[2]	LIU Heng-yang,WANG Jing-cheng,JIN Xiao-hong. Information System Application in Blood Transfusion Nursing Safety Management [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(4): 442-444.
[3]	SUN You-ling, LI Tao, XU Jin-jin, et al. Basic Evaluation Analysis of 31 Medical Records of Clinical Blood Transfusion in Northern Anhui [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2017, 19(3): 237-239.